John Alexander Bartlett

Professor of Medicine

Medicine, Infectious Diseases

bartl004@duke.edu

Duke Box 90519, Durham, NC 27710

235 Trent Hall, Durham, NC 27710

More About This Person

At a Glance

Credentials
1. Education

Academic Experience

Global Scholarship

Keywords

Research
1. Selected Grants
2. External Relationships

Scholarly Works

Teaching & Mentoring

Recognition
1. News Items

Professional Activities
1. Service to the Profession

Scholarly Works - Conferences

"They are not HIV treatments drugs; they are preventive drugs (PrEP)." Experiences of using PrEP among vulnerable adolescent girls and young women in Tanzania

Conference JOURNAL OF THE INTERNATIONAL AIDS SOCIETY · October 2024 Link to item Cite

Improving Cancer Care in the HIV Population: Qualitative Research to Identify Provider Knowledge, Attitudes and Practices

Conference INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS · November 1, 2022 Link to item Cite

Promoting uptake of evidence-based care for acute coronary syndrome in Tanzania: A prospective mixed-methods study

Conference IMPLEMENTATION SCIENCE · May 8, 2020 Link to item Cite

The Prevalence of Acute Myocardial Infarction Among Emergency Department Patients in Northern Tanzania

Conference CIRCULATION · November 19, 2019 Link to item Cite

FEASIBILITY OF A PRAGMATIC RANDOMIZED ADAPTIVE CLINICAL TRIAL OF A BRIEF INTERVENTION FOR ALCOHOL USE IN MOSHI, TANZANIA

Conference ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH · June 1, 2019 Link to item Cite

PA 12-5-2799 A practical trial: a pragmatic randomized adaptive clinical trial investigating controlling alcohol use and related harms in a low-income setting

Conference Abstracts · November 2018 Full text Cite

Lopinavir Population Pharmacokinetics in HIV-infected Patients from Resource-limited Settings Receiving Second-line Treatment with Lopinavir/Ritonavir Monotherapy in AIDS Clinical Trials Group (ACTG) Study 5230

Conference JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS · May 1, 2013 Link to item Cite

LEPTOSPIROSIS AMONG HOSPITALIZED PATIENTS WITH FEBRILE ILLNESS IN NORTHERN TANZANIA

Conference AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE · November 1, 2010 Link to item Cite

Progressive epigenetic deregulation of insulin-like growth factor 2 in cervical cancer precursors in HIV plus and HIV- patients

Conference GYNECOLOGIC ONCOLOGY · March 1, 2010 Link to item Cite

ETIOLOGY OF FEBRILE ILLNESS AMONG HOSPITALIZED HIV-INFECTED AND HIV-UNINFECTED ADULTS AND ADOLESCENTS IN NORTHERN TANZANIA

Conference AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE · November 1, 2009 Link to item Cite

HIV DISEASE AND BLOODSTREAM INFECTIONS AMONG FEBRILE PEDIATRIC HOSPITAL ADMISSIONS IN NORTHERN TANZANIA

Conference AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE · November 1, 2009 Link to item Cite

Detection of Cross-Clade T- and B-Cell-Mediated Immune Responses among HIV-1 Infected Individuals in Northern Tanzania

Conference AIDS RESEARCH AND HUMAN RETROVIRUSES · October 1, 2008 Link to item Cite

Clinical HIV/AIDS in sub-saharan Africa: new findings in a time of transition

Conference TROPICAL MEDICINE & INTERNATIONAL HEALTH · May 1, 2007 Link to item Cite

T1249-101: 14-day safety and antiviral activity of T-1249, a peptide inhibitor of membrane fusion

Conference ANTIVIRAL THERAPY · January 1, 2002 Link to item Cite

Pre valence of & risk factors for renal disease in a population-based sample of HIV-infected patients.

Conference AMERICAN JOURNAL OF KIDNEY DISEASES · April 1, 2001 Link to item Cite

HIV infection: Treatment and outcomes in younger and older patients

Conference JOURNAL OF THE AMERICAN GERIATRICS SOCIETY · August 1, 2000 Link to item Cite

Prolonged immunologic and virologic effects of 3TC and zidovudine in subjects who remained on blinded combination therapy beyond 52 weeks in two North American clinical trials

Conference AIDS · November 1, 1996 Link to item Cite

Reductions in HIV-1 disease progression for AZT/3TC relative to control treatments: A meta-analysis

Conference AIDS · November 1, 1996 Link to item Cite

ANTIGEN-SPECIFIC ACTIVATION/EXPANSION OF HUMAN ANTI-HIV CTL USING RECOMBINANT ALVAC (CANARYPOX)-BASED VECTORS

Conference JOURNAL OF CELLULAR BIOCHEMISTRY · April 2, 1995 Link to item Cite

Drug resistance and viral load in NUCA 3002: A comparative trial of lamivudine (3TC) (high or low dose)/zidovudine (ZDV) combination therapy vs ZDV/dideoxycytidine (ddC) combination therapy in ZDV-experienced (>=24 weeks) patients (CD4 cells 100-300/mm(3))

Conference JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY · January 1, 1995 Link to item Cite

CD8+T-LYMPHOCYTE-MEDIATED INHIBITION OF HIV-1 LTR TRANSCRIPTION

Conference AIDS RESEARCH AND HUMAN RETROVIRUSES · August 1, 1994 Link to item Cite

THE EFFECT OF INTERLEUKIN-7 ON FUNCTIONAL AND PHENOTYPIC PROPERTIES OF ANTIGEN-DRIVEN CTL

Conference JOURNAL OF CELLULAR BIOCHEMISTRY · January 1, 1994 Link to item Cite

CD8+ T-LYMPHOCYTES FROM ASYMPTOMATIC HIV-1 INFECTED INDIVIDUALS SUPPRESS TAT-MEDIATED HIV-1 LTR TRANSCRIPTION

Conference JOURNAL OF CELLULAR BIOCHEMISTRY · March 29, 1993 Link to item Cite

TH1 AND TH2 CD4 SUBSET RESPONSES IN HIV-1 INFECTED INDIVIDUALS AT VARIOUS STAGES OF DISEASE

Conference JOURNAL OF CELLULAR BIOCHEMISTRY · March 29, 1993 Link to item Cite

The antiretroviral effects of lymphokine-activated killer cells

Conference Surgical Forum · December 1, 1989 Cite